Martingale Asset Management L P Repligen Corp Transaction History

Martingale Asset Management L P

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 12, 2022	SELL	$161.19 - $257.96 $656,043 - $1.05 Million	-4,070 Closed	0 $0
Q4 2021 Feb 11, 2022	SELL	$247.59 - $304.47 $49,518 - $60,894	-200 Reduced 4.68%	4,070 $1.08 Million
Q3 2021 Nov 12, 2021	BUY	$194.77 - $324.21 $325,265 - $541,430	1,670 Added 64.23%	4,270 $1.23 Million
Q2 2021 Aug 13, 2021	SELL	$165.87 - $220.95 $19 Million - $25.3 Million	-114,287 Reduced 97.78%	2,600 $519,000
Q1 2021 May 13, 2021	BUY	$180.37 - $226.26 $1.11 Million - $1.4 Million	6,170 Added 5.57%	116,887 $22.7 Million
Q4 2020 Feb 10, 2021	BUY	$148.08 - $206.57 $12.8 Million - $17.9 Million	86,609 Added 359.25%	110,717 $21.2 Million
Q3 2020 Nov 12, 2020	BUY	$122.51 - $158.27 $122,755 - $158,586	1,002 Added 4.34%	24,108 $3.56 Million
Q2 2020 Aug 10, 2020	BUY	$94.33 - $140.48 $2.18 Million - $3.25 Million	23,106 New	23,106 $2.86 Million

488

54.2M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.59B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Martingale Asset Management L P, based on Form 13F filings with the SEC.

Stay updated on Martingale Asset Management L P with notifications on news.